| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Indaptus Therapeutics, Inc. (INDP) has 12 insiders with recent SEC Form 4 filings, including 16 buys and 2 sells. INDP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 229.9K | $402.4K | - | |
| Dir | 101.1K | $176.9K | - | |
| COO | 54.4K | $95.2K | - | |
| Dir | 30.0K | $52.5K | - | |
| CFO | 26.8K | $46.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2023 | Anderson Glen R. | 10% Owner | Buy | 103,352 | $2.09 | $216,388.00 | +3.1% | -10.5% | -32.7% | |
| Dec 1, 2022 | Litchev Boyan Vesselinov | Chief Medical Officer | Buy | 1,150 | $2.19 | $2,520.08 | +127.8% | -5.0% | +22.9% | |
| Nov 21, 2022 | Meckler Jeffrey A45 | CEO And Director | Buy | 10,000 | $1.89 | $18,945.48 | +7.6% | -2.8% | +15.5% | |
| Sep 8, 2022 | Meckler Jeffrey A45 | CEO And Director | Buy | 10,308 | $2.80 | $28,862.40 | +18.7% | -25.1% | +16.3% | |
| Sep 7, 2022 | Linscott Walt Addison | Chief Business Officer | Buy | 150 | $2.62 | $393.00 | New | -30.0% | +20.6% | |
| Sep 7, 2022 | Meckler Jeffrey A45 | CEO And Director | Buy | 9,692 | $2.56 | $24,770.64 | +10.6% | -30.0% | +20.6% | |
| Jun 6, 2022 | Meckler Jeffrey A45 | CEO And Director | Buy | 19,727 | $2.63 | $51,882.01 | +76.9% | -7.2% | -30.2% | |
| Feb 1, 2022 | Newman Michael James | CSO And Director | Sell | 20,000 | $5.00 | $100,042.98 | -0.7% | -37.6% | -65.8% | |
| Nov 18, 2021 | Meckler Jeffrey A45 | CEO And Director | Buy | 11,187 | $5.82 | $65,108.34 | +77.4% | -7.5% | -67.6% | |
| Sep 14, 2021 | Meckler Jeffrey A45 | CEO And Director | Buy | 12,000 | $7.00 | $84,000.00 | +487.8% | -10.6% | -63.2% |